Glucotrol Xl
Glipizide extended-release tablets for type 2 diabetes. The prolonged release keeps the pancreas nudged to make insulin steadily, rather than in one short burst.
All strengths and pack prices
| Strength | Pack | Price | Per unit |
|---|---|---|---|
| 2.5mg | 30 tablets | $11.00 | $0.37 |
| 2.5mg | 60 tablets | $14.00 | $0.23 |
| 2.5mg | 90 tablets | $18.00 | $0.20 |
| 2.5mg | 180 tablets | $33.00 | $0.18 |
| 2.5mg | 270 tablets | $43.00 | $0.16 |
| 5mg | 30 tablets | $63.00 | $2.10 |
| 5mg | 60 tablets | $126.00 | $2.10 |
| 5mg | 90 tablets | $180.00 | $2.00 |
| 5mg | 120 tablets | $229.00 | $1.91 |
| 5mg | 180 tablets | $323.00 | $1.79 |
| 5mg | 360 tablets | $610.00 | $1.69 |
| 10mg | 90 tablets | $81.00 | $0.90 |
| 10mg | 120 tablets | $97.00 | $0.81 |
| 10mg | 180 tablets | $126.00 | $0.70 |
| 10mg | 270 tablets | $170.00 | $0.63 |
| 10mg | 360 tablets | $216.00 | $0.60 |
- Category
- Diabetes Management
- Active ingredient
- Glipizide
- Route
- Oral use
- Form
- Extended-Release Tablet
- Strengths
- 2.5mg · 5mg · 10mg
No prescription needed: we place your order for Glucotrol Xl on your behalf.
Glucotrol Xl details
- Condition
- Type 2 Diabetes Mellitus
- Alternative names
- glipizide
- Therapeutic class
- Sulfonylurea
- Pharmacological class
- Antidiabetic
- Contraindications
- diabetic ketoacidosis; type 1 diabetes mellitus; severe hepatic impairment
- Minor side effects
- nausea; dizziness; headache
- Moderate side effects
- hypoglycaemia; weight gain; flatulence
- Dosage forms
- Extended-Release Tablet
- Administration route
- Oral use
- Manufacturer
- Pfizer
- Onset time
- 1–3 hours
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- NSAIDs; Warfarin; Beta Blockers
- Age restrictions
- Approved for adults.
Serious side effects
severe hypoglycaemia, requires immediate medical attention; haemolytic anaemia, requires immediate medical attention
Patient summary
Glipizide extended-release tablets for type 2 diabetes. The prolonged release keeps the pancreas nudged to make insulin steadily, rather than in one short burst.
Mechanism of action
Stimulates beta cells in the pancreas to release endogenous insulin, reducing circulating postprandial glucose levels.
Pregnancy and breastfeeding
Pregnancy: Avoid in late pregnancy due to risk of neonatal hypoglycaemia. Breastfeeding: Not recommended.